KEGG enrichment analysis suggested that 4a may exert anti-breast cancer effects by participating in the PI3K-Akt signaling pathway, endocrine resistance, MAPK signaling pathway, and other breast cancer-related pathways. This evidence concerns the gene AKT1 and breast cancer.